Hua Hua
Director/Board Member at Infervision Medical Technology Co., Ltd.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Nan Wu | M | 43 |
Infervision Medical Technology Co., Ltd.
Infervision Medical Technology Co., Ltd. Packaged SoftwareTechnology Services Infervision Medical Technology Co., Ltd. engages in the research and development, and provision of artificial intelligence technology in assisting medical image diagnosis. Its AI medical products intended for disease screening and diagnosis, disease intervention and treatment, patient management and medical research, for full-hospital deployment serving physicians from multiple departments. The firm’s products include InferRead Solution and InferScholar Center. The company was founded on January 5, 2016 and is headquartered in Beijing, China. | 4 years |
Lam Sin Lai Tsui | M | 69 |
Infervision Medical Technology Co., Ltd.
Infervision Medical Technology Co., Ltd. Packaged SoftwareTechnology Services Infervision Medical Technology Co., Ltd. engages in the research and development, and provision of artificial intelligence technology in assisting medical image diagnosis. Its AI medical products intended for disease screening and diagnosis, disease intervention and treatment, patient management and medical research, for full-hospital deployment serving physicians from multiple departments. The firm’s products include InferRead Solution and InferScholar Center. The company was founded on January 5, 2016 and is headquartered in Beijing, China. | 3 years |
Wei Ying Xu | F | 53 |
Infervision Medical Technology Co., Ltd.
Infervision Medical Technology Co., Ltd. Packaged SoftwareTechnology Services Infervision Medical Technology Co., Ltd. engages in the research and development, and provision of artificial intelligence technology in assisting medical image diagnosis. Its AI medical products intended for disease screening and diagnosis, disease intervention and treatment, patient management and medical research, for full-hospital deployment serving physicians from multiple departments. The firm’s products include InferRead Solution and InferScholar Center. The company was founded on January 5, 2016 and is headquartered in Beijing, China. | 4 years |
Xiao Yuan Feng | M | 67 |
Infervision Medical Technology Co., Ltd.
Infervision Medical Technology Co., Ltd. Packaged SoftwareTechnology Services Infervision Medical Technology Co., Ltd. engages in the research and development, and provision of artificial intelligence technology in assisting medical image diagnosis. Its AI medical products intended for disease screening and diagnosis, disease intervention and treatment, patient management and medical research, for full-hospital deployment serving physicians from multiple departments. The firm’s products include InferRead Solution and InferScholar Center. The company was founded on January 5, 2016 and is headquartered in Beijing, China. | 4 years |
Shao Kang Wang | M | 36 |
Infervision Medical Technology Co., Ltd.
Infervision Medical Technology Co., Ltd. Packaged SoftwareTechnology Services Infervision Medical Technology Co., Ltd. engages in the research and development, and provision of artificial intelligence technology in assisting medical image diagnosis. Its AI medical products intended for disease screening and diagnosis, disease intervention and treatment, patient management and medical research, for full-hospital deployment serving physicians from multiple departments. The firm’s products include InferRead Solution and InferScholar Center. The company was founded on January 5, 2016 and is headquartered in Beijing, China. | 8 years |
Yi Fei Fan | M | 60 |
China Investment Corp.
China Investment Corp. Financial ConglomeratesFinance China Investment Corp. (CIC) is a wholly state-owned investment institution which was established in 2007 under the Company Law of the People's Republic of China to hold, manage and invest their mandated assets to maximize shareholder's value. Headquartered in Beijing, CIC's activities include domestic investments in debt securities denominated in foreign currencies and other financial products denominated in foreign currencies; overseas investments in debt securities, stocks, funds and derivative instruments and other financial products; domestic and overseas equity investments; overseas investments through external fund managers; provision of loans through entrusted financial institutions; management of entrusted foreign exchange assets; establishment of equity investment funds and fund management companies as a promoter and other businesses approved by the relevant governmental authorities. The firm invests in domestic financial institutions primarily through their wholly-owned subsidiary, Central Huijin Investment Ltd. While they operate independently, CIC remains accountable to the State Council of the People's Republic of China and, ultimately, to the citizens of the People's Republic of China. Their investments are not limited to any particular sector, geography or asset class and include equity, fixed-income and alternative assets. | 14 years |
Kuan Chen | M | 36 |
Infervision Medical Technology Co., Ltd.
Infervision Medical Technology Co., Ltd. Packaged SoftwareTechnology Services Infervision Medical Technology Co., Ltd. engages in the research and development, and provision of artificial intelligence technology in assisting medical image diagnosis. Its AI medical products intended for disease screening and diagnosis, disease intervention and treatment, patient management and medical research, for full-hospital deployment serving physicians from multiple departments. The firm’s products include InferRead Solution and InferScholar Center. The company was founded on January 5, 2016 and is headquartered in Beijing, China. | 8 years |
Jinqi Su | M | 61 |
Infervision Medical Technology Co., Ltd.
Infervision Medical Technology Co., Ltd. Packaged SoftwareTechnology Services Infervision Medical Technology Co., Ltd. engages in the research and development, and provision of artificial intelligence technology in assisting medical image diagnosis. Its AI medical products intended for disease screening and diagnosis, disease intervention and treatment, patient management and medical research, for full-hospital deployment serving physicians from multiple departments. The firm’s products include InferRead Solution and InferScholar Center. The company was founded on January 5, 2016 and is headquartered in Beijing, China. | 3 years |
Shice Wang | M | 29 |
Infervision Medical Technology Co., Ltd.
Infervision Medical Technology Co., Ltd. Packaged SoftwareTechnology Services Infervision Medical Technology Co., Ltd. engages in the research and development, and provision of artificial intelligence technology in assisting medical image diagnosis. Its AI medical products intended for disease screening and diagnosis, disease intervention and treatment, patient management and medical research, for full-hospital deployment serving physicians from multiple departments. The firm’s products include InferRead Solution and InferScholar Center. The company was founded on January 5, 2016 and is headquartered in Beijing, China. | 4 years |
Kun Wang | M | 40 |
Infervision Medical Technology Co., Ltd.
Infervision Medical Technology Co., Ltd. Packaged SoftwareTechnology Services Infervision Medical Technology Co., Ltd. engages in the research and development, and provision of artificial intelligence technology in assisting medical image diagnosis. Its AI medical products intended for disease screening and diagnosis, disease intervention and treatment, patient management and medical research, for full-hospital deployment serving physicians from multiple departments. The firm’s products include InferRead Solution and InferScholar Center. The company was founded on January 5, 2016 and is headquartered in Beijing, China. | 4 years |
Lei Du | M | 37 |
Infervision Medical Technology Co., Ltd.
Infervision Medical Technology Co., Ltd. Packaged SoftwareTechnology Services Infervision Medical Technology Co., Ltd. engages in the research and development, and provision of artificial intelligence technology in assisting medical image diagnosis. Its AI medical products intended for disease screening and diagnosis, disease intervention and treatment, patient management and medical research, for full-hospital deployment serving physicians from multiple departments. The firm’s products include InferRead Solution and InferScholar Center. The company was founded on January 5, 2016 and is headquartered in Beijing, China. | 3 years |
Olivia Mitchell | F | 71 |
The Wharton School of the University of Pennsylvania
| 31 years |
Jian Yue Zhang | M | - |
China Investment Corp.
China Investment Corp. Financial ConglomeratesFinance China Investment Corp. (CIC) is a wholly state-owned investment institution which was established in 2007 under the Company Law of the People's Republic of China to hold, manage and invest their mandated assets to maximize shareholder's value. Headquartered in Beijing, CIC's activities include domestic investments in debt securities denominated in foreign currencies and other financial products denominated in foreign currencies; overseas investments in debt securities, stocks, funds and derivative instruments and other financial products; domestic and overseas equity investments; overseas investments through external fund managers; provision of loans through entrusted financial institutions; management of entrusted foreign exchange assets; establishment of equity investment funds and fund management companies as a promoter and other businesses approved by the relevant governmental authorities. The firm invests in domestic financial institutions primarily through their wholly-owned subsidiary, Central Huijin Investment Ltd. While they operate independently, CIC remains accountable to the State Council of the People's Republic of China and, ultimately, to the citizens of the People's Republic of China. Their investments are not limited to any particular sector, geography or asset class and include equity, fixed-income and alternative assets. | 15 years |
Shi Ping Wei | M | 52 |
China Investment Corp.
China Investment Corp. Financial ConglomeratesFinance China Investment Corp. (CIC) is a wholly state-owned investment institution which was established in 2007 under the Company Law of the People's Republic of China to hold, manage and invest their mandated assets to maximize shareholder's value. Headquartered in Beijing, CIC's activities include domestic investments in debt securities denominated in foreign currencies and other financial products denominated in foreign currencies; overseas investments in debt securities, stocks, funds and derivative instruments and other financial products; domestic and overseas equity investments; overseas investments through external fund managers; provision of loans through entrusted financial institutions; management of entrusted foreign exchange assets; establishment of equity investment funds and fund management companies as a promoter and other businesses approved by the relevant governmental authorities. The firm invests in domestic financial institutions primarily through their wholly-owned subsidiary, Central Huijin Investment Ltd. While they operate independently, CIC remains accountable to the State Council of the People's Republic of China and, ultimately, to the citizens of the People's Republic of China. Their investments are not limited to any particular sector, geography or asset class and include equity, fixed-income and alternative assets. | 15 years |
Olivia Ouyang | F | 52 |
China Investment Corp.
China Investment Corp. Financial ConglomeratesFinance China Investment Corp. (CIC) is a wholly state-owned investment institution which was established in 2007 under the Company Law of the People's Republic of China to hold, manage and invest their mandated assets to maximize shareholder's value. Headquartered in Beijing, CIC's activities include domestic investments in debt securities denominated in foreign currencies and other financial products denominated in foreign currencies; overseas investments in debt securities, stocks, funds and derivative instruments and other financial products; domestic and overseas equity investments; overseas investments through external fund managers; provision of loans through entrusted financial institutions; management of entrusted foreign exchange assets; establishment of equity investment funds and fund management companies as a promoter and other businesses approved by the relevant governmental authorities. The firm invests in domestic financial institutions primarily through their wholly-owned subsidiary, Central Huijin Investment Ltd. While they operate independently, CIC remains accountable to the State Council of the People's Republic of China and, ultimately, to the citizens of the People's Republic of China. Their investments are not limited to any particular sector, geography or asset class and include equity, fixed-income and alternative assets. | 14 years |
Lei Xue | M | 64 |
Tsinghua University
| 42 years |
Siu Pik Ho | F | 60 |
Infervision Medical Technology Co., Ltd.
Infervision Medical Technology Co., Ltd. Packaged SoftwareTechnology Services Infervision Medical Technology Co., Ltd. engages in the research and development, and provision of artificial intelligence technology in assisting medical image diagnosis. Its AI medical products intended for disease screening and diagnosis, disease intervention and treatment, patient management and medical research, for full-hospital deployment serving physicians from multiple departments. The firm’s products include InferRead Solution and InferScholar Center. The company was founded on January 5, 2016 and is headquartered in Beijing, China. | 3 years |
Chun Peng | M | 63 |
China Investment Corp.
China Investment Corp. Financial ConglomeratesFinance China Investment Corp. (CIC) is a wholly state-owned investment institution which was established in 2007 under the Company Law of the People's Republic of China to hold, manage and invest their mandated assets to maximize shareholder's value. Headquartered in Beijing, CIC's activities include domestic investments in debt securities denominated in foreign currencies and other financial products denominated in foreign currencies; overseas investments in debt securities, stocks, funds and derivative instruments and other financial products; domestic and overseas equity investments; overseas investments through external fund managers; provision of loans through entrusted financial institutions; management of entrusted foreign exchange assets; establishment of equity investment funds and fund management companies as a promoter and other businesses approved by the relevant governmental authorities. The firm invests in domestic financial institutions primarily through their wholly-owned subsidiary, Central Huijin Investment Ltd. While they operate independently, CIC remains accountable to the State Council of the People's Republic of China and, ultimately, to the citizens of the People's Republic of China. Their investments are not limited to any particular sector, geography or asset class and include equity, fixed-income and alternative assets. | 14 years |
Jian Chen | M | 72 |
China Investment Corp.
China Investment Corp. Financial ConglomeratesFinance China Investment Corp. (CIC) is a wholly state-owned investment institution which was established in 2007 under the Company Law of the People's Republic of China to hold, manage and invest their mandated assets to maximize shareholder's value. Headquartered in Beijing, CIC's activities include domestic investments in debt securities denominated in foreign currencies and other financial products denominated in foreign currencies; overseas investments in debt securities, stocks, funds and derivative instruments and other financial products; domestic and overseas equity investments; overseas investments through external fund managers; provision of loans through entrusted financial institutions; management of entrusted foreign exchange assets; establishment of equity investment funds and fund management companies as a promoter and other businesses approved by the relevant governmental authorities. The firm invests in domestic financial institutions primarily through their wholly-owned subsidiary, Central Huijin Investment Ltd. While they operate independently, CIC remains accountable to the State Council of the People's Republic of China and, ultimately, to the citizens of the People's Republic of China. Their investments are not limited to any particular sector, geography or asset class and include equity, fixed-income and alternative assets. | 13 years |
Qing Zhang | M | 55 |
China Investment Corp.
China Investment Corp. Financial ConglomeratesFinance China Investment Corp. (CIC) is a wholly state-owned investment institution which was established in 2007 under the Company Law of the People's Republic of China to hold, manage and invest their mandated assets to maximize shareholder's value. Headquartered in Beijing, CIC's activities include domestic investments in debt securities denominated in foreign currencies and other financial products denominated in foreign currencies; overseas investments in debt securities, stocks, funds and derivative instruments and other financial products; domestic and overseas equity investments; overseas investments through external fund managers; provision of loans through entrusted financial institutions; management of entrusted foreign exchange assets; establishment of equity investment funds and fund management companies as a promoter and other businesses approved by the relevant governmental authorities. The firm invests in domestic financial institutions primarily through their wholly-owned subsidiary, Central Huijin Investment Ltd. While they operate independently, CIC remains accountable to the State Council of the People's Republic of China and, ultimately, to the citizens of the People's Republic of China. Their investments are not limited to any particular sector, geography or asset class and include equity, fixed-income and alternative assets. | 15 years |
Ye Wang | M | 66 |
Infervision Medical Technology Co., Ltd.
Infervision Medical Technology Co., Ltd. Packaged SoftwareTechnology Services Infervision Medical Technology Co., Ltd. engages in the research and development, and provision of artificial intelligence technology in assisting medical image diagnosis. Its AI medical products intended for disease screening and diagnosis, disease intervention and treatment, patient management and medical research, for full-hospital deployment serving physicians from multiple departments. The firm’s products include InferRead Solution and InferScholar Center. The company was founded on January 5, 2016 and is headquartered in Beijing, China. | 3 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Shao Ping Ma | M | 63 |
Tsinghua University
| 19 years |
Ke Ping Li | M | 68 |
China Investment Corp.
China Investment Corp. Financial ConglomeratesFinance China Investment Corp. (CIC) is a wholly state-owned investment institution which was established in 2007 under the Company Law of the People's Republic of China to hold, manage and invest their mandated assets to maximize shareholder's value. Headquartered in Beijing, CIC's activities include domestic investments in debt securities denominated in foreign currencies and other financial products denominated in foreign currencies; overseas investments in debt securities, stocks, funds and derivative instruments and other financial products; domestic and overseas equity investments; overseas investments through external fund managers; provision of loans through entrusted financial institutions; management of entrusted foreign exchange assets; establishment of equity investment funds and fund management companies as a promoter and other businesses approved by the relevant governmental authorities. The firm invests in domestic financial institutions primarily through their wholly-owned subsidiary, Central Huijin Investment Ltd. While they operate independently, CIC remains accountable to the State Council of the People's Republic of China and, ultimately, to the citizens of the People's Republic of China. Their investments are not limited to any particular sector, geography or asset class and include equity, fixed-income and alternative assets. | - |
Xi Qing Gao | M | 71 |
China Investment Corp.
China Investment Corp. Financial ConglomeratesFinance China Investment Corp. (CIC) is a wholly state-owned investment institution which was established in 2007 under the Company Law of the People's Republic of China to hold, manage and invest their mandated assets to maximize shareholder's value. Headquartered in Beijing, CIC's activities include domestic investments in debt securities denominated in foreign currencies and other financial products denominated in foreign currencies; overseas investments in debt securities, stocks, funds and derivative instruments and other financial products; domestic and overseas equity investments; overseas investments through external fund managers; provision of loans through entrusted financial institutions; management of entrusted foreign exchange assets; establishment of equity investment funds and fund management companies as a promoter and other businesses approved by the relevant governmental authorities. The firm invests in domestic financial institutions primarily through their wholly-owned subsidiary, Central Huijin Investment Ltd. While they operate independently, CIC remains accountable to the State Council of the People's Republic of China and, ultimately, to the citizens of the People's Republic of China. Their investments are not limited to any particular sector, geography or asset class and include equity, fixed-income and alternative assets. | - |
Keith Abell | M | 66 |
University of Pennsylvania
| 2 years |
Matthew Young | M | 54 |
The Wharton School of the University of Pennsylvania
| 5 years |
Roger Merritt | M | - |
University of Pennsylvania
| 3 years |
Kenneth Robert Marcus | M | - |
University of Pennsylvania
| 5 years |
Fritz Thomas | M | - |
University of Pennsylvania
| 6 years |
Justin Warren Slatky | M | - |
The Wharton School of the University of Pennsylvania
| 5 years |
Hao Ming Chen | M | 77 |
Tsinghua University
| 18 years |
Janet Cowell | F | 54 |
The Wharton School of the University of Pennsylvania
University of Pennsylvania
| 7 years |
Xue Dong Ding | M | 64 |
China Investment Corp.
China Investment Corp. Financial ConglomeratesFinance China Investment Corp. (CIC) is a wholly state-owned investment institution which was established in 2007 under the Company Law of the People's Republic of China to hold, manage and invest their mandated assets to maximize shareholder's value. Headquartered in Beijing, CIC's activities include domestic investments in debt securities denominated in foreign currencies and other financial products denominated in foreign currencies; overseas investments in debt securities, stocks, funds and derivative instruments and other financial products; domestic and overseas equity investments; overseas investments through external fund managers; provision of loans through entrusted financial institutions; management of entrusted foreign exchange assets; establishment of equity investment funds and fund management companies as a promoter and other businesses approved by the relevant governmental authorities. The firm invests in domestic financial institutions primarily through their wholly-owned subsidiary, Central Huijin Investment Ltd. While they operate independently, CIC remains accountable to the State Council of the People's Republic of China and, ultimately, to the citizens of the People's Republic of China. Their investments are not limited to any particular sector, geography or asset class and include equity, fixed-income and alternative assets. | - |
Yong Zhu | M | 55 |
China Investment Corp.
China Investment Corp. Financial ConglomeratesFinance China Investment Corp. (CIC) is a wholly state-owned investment institution which was established in 2007 under the Company Law of the People's Republic of China to hold, manage and invest their mandated assets to maximize shareholder's value. Headquartered in Beijing, CIC's activities include domestic investments in debt securities denominated in foreign currencies and other financial products denominated in foreign currencies; overseas investments in debt securities, stocks, funds and derivative instruments and other financial products; domestic and overseas equity investments; overseas investments through external fund managers; provision of loans through entrusted financial institutions; management of entrusted foreign exchange assets; establishment of equity investment funds and fund management companies as a promoter and other businesses approved by the relevant governmental authorities. The firm invests in domestic financial institutions primarily through their wholly-owned subsidiary, Central Huijin Investment Ltd. While they operate independently, CIC remains accountable to the State Council of the People's Republic of China and, ultimately, to the citizens of the People's Republic of China. Their investments are not limited to any particular sector, geography or asset class and include equity, fixed-income and alternative assets. | - |
David Anderman | M | - |
University of Pennsylvania
| 4 years |
Hao Ling Liu | M | 52 |
China Investment Corp.
China Investment Corp. Financial ConglomeratesFinance China Investment Corp. (CIC) is a wholly state-owned investment institution which was established in 2007 under the Company Law of the People's Republic of China to hold, manage and invest their mandated assets to maximize shareholder's value. Headquartered in Beijing, CIC's activities include domestic investments in debt securities denominated in foreign currencies and other financial products denominated in foreign currencies; overseas investments in debt securities, stocks, funds and derivative instruments and other financial products; domestic and overseas equity investments; overseas investments through external fund managers; provision of loans through entrusted financial institutions; management of entrusted foreign exchange assets; establishment of equity investment funds and fund management companies as a promoter and other businesses approved by the relevant governmental authorities. The firm invests in domestic financial institutions primarily through their wholly-owned subsidiary, Central Huijin Investment Ltd. While they operate independently, CIC remains accountable to the State Council of the People's Republic of China and, ultimately, to the citizens of the People's Republic of China. Their investments are not limited to any particular sector, geography or asset class and include equity, fixed-income and alternative assets. | 3 years |
Hou Min Yan | M | 69 |
Tsinghua University
| 7 years |
Wen Yao | M | 54 |
China Investment Corp.
China Investment Corp. Financial ConglomeratesFinance China Investment Corp. (CIC) is a wholly state-owned investment institution which was established in 2007 under the Company Law of the People's Republic of China to hold, manage and invest their mandated assets to maximize shareholder's value. Headquartered in Beijing, CIC's activities include domestic investments in debt securities denominated in foreign currencies and other financial products denominated in foreign currencies; overseas investments in debt securities, stocks, funds and derivative instruments and other financial products; domestic and overseas equity investments; overseas investments through external fund managers; provision of loans through entrusted financial institutions; management of entrusted foreign exchange assets; establishment of equity investment funds and fund management companies as a promoter and other businesses approved by the relevant governmental authorities. The firm invests in domestic financial institutions primarily through their wholly-owned subsidiary, Central Huijin Investment Ltd. While they operate independently, CIC remains accountable to the State Council of the People's Republic of China and, ultimately, to the citizens of the People's Republic of China. Their investments are not limited to any particular sector, geography or asset class and include equity, fixed-income and alternative assets. | 5 years |
Wei Zhen Sun | M | 61 |
Tsinghua University
| 7 years |
Jian Cun Gao | M | 62 |
Tsinghua University
| 7 years |
Zhi He Meng | M | 69 |
Tsinghua University
| 7 years |
Jian Liu | M | 51 |
China Investment Corp.
China Investment Corp. Financial ConglomeratesFinance China Investment Corp. (CIC) is a wholly state-owned investment institution which was established in 2007 under the Company Law of the People's Republic of China to hold, manage and invest their mandated assets to maximize shareholder's value. Headquartered in Beijing, CIC's activities include domestic investments in debt securities denominated in foreign currencies and other financial products denominated in foreign currencies; overseas investments in debt securities, stocks, funds and derivative instruments and other financial products; domestic and overseas equity investments; overseas investments through external fund managers; provision of loans through entrusted financial institutions; management of entrusted foreign exchange assets; establishment of equity investment funds and fund management companies as a promoter and other businesses approved by the relevant governmental authorities. The firm invests in domestic financial institutions primarily through their wholly-owned subsidiary, Central Huijin Investment Ltd. While they operate independently, CIC remains accountable to the State Council of the People's Republic of China and, ultimately, to the citizens of the People's Republic of China. Their investments are not limited to any particular sector, geography or asset class and include equity, fixed-income and alternative assets. | 6 years |
Yi Shun Han | M | 65 |
Tsinghua University
| 7 years |
Marc McMorris | M | 55 |
The Wharton School of the University of Pennsylvania
University of Pennsylvania
| 7 years |
Richard Fu | M | - |
Tsinghua University
| 2 years |
Maja M. Gross | F | - |
The Wharton School of the University of Pennsylvania
| 6 years |
Andrew Pearson | M | 52 |
The Wharton School of the University of Pennsylvania
| 4 years |
Robert J. Fioretti | M | - |
University of Pennsylvania
| 12 years |
Michael Rotgin | M | - |
The Wharton School of the University of Pennsylvania
University of Pennsylvania
| 4 years |
Liji Huang | M | - |
Tsinghua University
| 7 years |
Lawrence Berger | M | 52 |
The Wharton School of the University of Pennsylvania
| 4 years |
Henry Woo | M | - |
University of Pennsylvania
The Wharton School of the University of Pennsylvania
| 4 years |
Elizabeth Granville-Smith | F | - |
The Wharton School of the University of Pennsylvania
University of Pennsylvania
| 7 years |
Phil Bronner | M | 53 |
The Wharton School of the University of Pennsylvania
| 3 years |
Alex Gorsky | M | 63 |
The Wharton School of the University of Pennsylvania
| 2 years |
James Asali | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
Yale Jacob Baron | M | - |
The Wharton School of the University of Pennsylvania
| 3 years |
Mark Alan Mowrey | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
Eric Filipek | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
Luv Dinesh Parikh | M | 48 |
The Wharton School of the University of Pennsylvania
| 4 years |
Marla Blow | F | 53 |
The Wharton School of the University of Pennsylvania
| 4 years |
Marc A. Singer | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
Alberto Ribeiro Guth | M | 64 |
The Wharton School of the University of Pennsylvania
| 2 years |
Keith Alexander | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
James G. Brown | M | 58 |
The Wharton School of the University of Pennsylvania
| 2 years |
Marc Becker | M | 51 |
The Wharton School of the University of Pennsylvania
| 4 years |
Roger Cozzi | M | 54 |
The Wharton School of the University of Pennsylvania
| 4 years |
Christopher Thomas | M | 49 |
The Wharton School of the University of Pennsylvania
| 4 years |
Pauline Brown | F | 58 |
The Wharton School of the University of Pennsylvania
| 2 years |
Elizabeth Wahab | F | - |
The Wharton School of the University of Pennsylvania
| 2 years |
Thomas Nolan | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
Andrie Setiawan Yapsir | M | 64 |
The Wharton School of the University of Pennsylvania
| 2 years |
Brett Albert | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
Joseph Higgins | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
Timothy Fazio | M | 50 |
The Wharton School of the University of Pennsylvania
| 4 years |
Borthwick John | M | 58 |
The Wharton School of the University of Pennsylvania
| 2 years |
Samantha Joy Greenberg | F | - |
The Wharton School of the University of Pennsylvania
| 4 years |
Theodore Coons | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
Judith W. Ottensoser | F | - |
The Wharton School of the University of Pennsylvania
| 4 years |
David B. Rubenstein | M | - |
The Wharton School of the University of Pennsylvania
| 2 years |
Goodwin Gaw | M | 53 |
The Wharton School of the University of Pennsylvania
| 4 years |
Atif U. Gilani | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
David S. Schechter | M | 47 |
The Wharton School of the University of Pennsylvania
| 4 years |
Michael Trica | M | 48 |
The Wharton School of the University of Pennsylvania
| 4 years |
Jordan Ruddy | M | 61 |
The Wharton School of the University of Pennsylvania
| 2 years |
Marc A. Schneider | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
Josh Birnbaum | M | - |
The Wharton School of the University of Pennsylvania
| 3 years |
Dong Liu | M | 60 |
The Wharton School of the University of Pennsylvania
| 3 years |
Mayur Piyush Patel | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
Michael Claude Kass | M | 50 |
The Wharton School of the University of Pennsylvania
| 4 years |
Jason Haber Karp | M | 47 |
The Wharton School of the University of Pennsylvania
| 4 years |
Jeanette L. Ourada | F | 58 |
The Wharton School of the University of Pennsylvania
| 2 years |
Sam Oh | M | 54 |
The Wharton School of the University of Pennsylvania
| 4 years |
Hossam Ali H. Shobokshi | M | - |
The Wharton School of the University of Pennsylvania
| 3 years |
Daniel Gardenswartz | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
Peter B. Oleksiak | M | 57 |
The Wharton School of the University of Pennsylvania
| 2 years |
Thomas Sullivan | M | 60 |
The Wharton School of the University of Pennsylvania
| 2 years |
Sandor Hau | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
Michael Fieldstone | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
Michael W. Green | M | - |
The Wharton School of the University of Pennsylvania
| 4 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 64 | 64.00% |
China | 36 | 36.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Hua Hua
- Personal Network